Republican Rep. Michael Fitzpatrick (PA) told members of an FDA panel Tuesday (April 21) that it is time to have an “open conversation” about safety in the medical device industry, adding that he has asked “relevant congressional committees” on the House side to reengage in an oversight capacity and to look at the 510(k) process. The move comes as consumer advocates urge House lawmakers to shy away from proposals in the draft 21st Century Cures bill that they say would...